Furthermore, all patients with non-insulin-dependent diabetes and with moderate PEI (fecal elastase concentrations <200 μg/g) were excluded, and insulin, glucagon, and incretin levels, that might be modified by the enzymatic treatment, were not assessed [17]. The gene discussed is INS; the disease is type 1 diabetes mellitus.